Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06612970
PHASE1

A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

The aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose.

Official title: A Phase 1a, Randomized, Double-blind, Placebo-controlled, Single Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HB0056 in Adult Healthy Subjects.

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

46

Start Date

2024-11-18

Completion Date

2025-10-01

Last Updated

2025-09-08

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

HB0056

HB0056 Injection

DRUG

Placebo

Placebo

Locations (1)

New Zealand Clinical Research

Christchurch, New Zealand